ABBV
AbbVie Inc. · Healthcare · Drug Manufacturers - General
Momentum-inputs (vergelijkbare managers):
breedte van houders +8.7% ·
aandelenstroom -0.3% ·
netto nieuwe posities +8.0%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 181 | +6 | 1.06B | $267.14B | +9 | −4 |
| Q1 2026 | 179 | -3 | 1.05B | $227.15B | +2 | −6 |
| Q4 2025 | 181 | -3 | 1.14B | $259.75B | +1 | −3 |
| Q3 2025 | 27 | 0 | 673.15M | $155.83B | — | −1 |
| Q2 2025 | 25 | +2 | 519.81M | $96.45B | +2 | — |
| Q1 2025 | 20 | 0 | 175.76M | $36.80B | — | — |
| Q4 2024 | 20 | 0 | 178.61M | $31.72B | — | — |
| Q3 2024 | 19 | 0 | 95.00M | $18.73B | +1 | −1 |
| Q2 2024 | 19 | — | 90.79M | $15.55B | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 177.30M | — | $32.91B | 0.5% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passief) | 147.46M | — | $27.37B | 0.5% | n/c | 1 | SEC ↗ ×24 |
| 3 | State Street Global Advisors ✦ (passief) | 80.02M | +0.1% | $14.85B | 0.6% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passief) | 39.18M | +2.4% | $7.24B | 0.5% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Norges Bank ✦ (passief) | 23.10M | -5.7% | $4.29B | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 6 | Fidelity (FMR) ✦ | 21.00M | — | $3.90B | 0.2% | n/c | 1 | SEC ↗ ×6 |
| 7 | T. Rowe Price ✦ | 9.06M | +25.9% | $1.68B | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 8 | Capital World Investors ✦ | 6.47M | -60.0% | $1.20B | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 3.25M | +76.1% | $603.80M | 0.5% | ▲ Add | 4 | SEC ↗ ×2 |
| 10 | Millennium Management ✦ | 2.45M | +415.9% | $454.14M | 0.4% | ▲ Add | 5 | SEC ↗ |
| 11 | Renaissance Technologies ✦ | 1.96M | +60.5% | $364.19M | 0.5% | ▲ Add | 5 | SEC ↗ |
| 12 | Wellington Management ✦ | 1.89M | +4.3% | $350.91M | 0.1% | ▲ Add | 5 | SEC ↗ ×8 |
| 13 | Adage Capital Partners ✦ | 1.62M | -10.0% | $300.49M | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 1.54M | +147.6% | $286.01M | 0.3% | ▲ Add | 5 | SEC ↗ ×2 |
| 15 | Marshall Wace ✦ | 1.38M | +470.5% | $256.03M | 0.3% | ▲ Add | 5 | SEC ↗ ×3 |
| 16 | Bridgewater Associates ✦ | 598.29K | +470.1% | $111.05M | 0.4% | ▲ Add | 5 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 597.99K | -22.8% | $109.73M | 0.1% | ▼ Trim | 5 | SEC ↗ ×7 |
| 18 | Arrowstreet Capital ✦ | 316.71K | -12.5% | $58.79M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Fisher Asset Management ✦ | 283.58K | -20.7% | $52.64M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 255.88K | +2011.5% | $47.50M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 36.77K | +13.2% | $6.83M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | GAMCO Investors ✦ | 15.75K | +18.0% | $2.92M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Dodge & Cox ✦ | 10.47K | 0.0% | $1.94M | 0.0% | Held | 5 | SEC ↗ |
| 24 | Point72 Asset Management ✦ | 5.21K | Nieuw | $967,106 | 0.0% | New | 1 | SEC ↗ |
| 25 | Harris Associates (Oakmark) ✦ | 3.16K | Nieuw | $587,116 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Point72 Asset Management | $967,106 | 0.0% |
| Harris Associates (Oakmark) | $587,116 | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 4,042 houders, 1.24B aandelen, $260.03B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 32.71K aand · $8.18M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie